The Size of the Global Europe Dialysis Equipment Market is expected to grow at a CAGR of 5.4% and to reach USD 5.59 billion by 2026, from USD 4.30 billion in 2021 during the forecast period 2021 to 2026.
DRIVERS
The increase in cases related to hypertension and diabetes is the vital factor that intensifies the growth of the market, along with the increase in the number of geriatric people in the world, the increase in expenditure related to research and development. In the healthcare sector, the increased demand for cost-effective portable dialysis devices and equipment due to the high costs associated with kidney transplantation and the increase in lifestyle-related illnesses due to unhealthy eating habits are the main factors, among others, which stimulate the renal dialysis equipment market.
The prevalence of kidney failure has skyrocketed in intensive care units in hospitals around the world, creating a worrying shortage of dialysis machines and even dialysis solution. The physiology of the trajectory and burden of acute kidney injury (AKI) associated with COVID-19 is increasing as the number of older people infected with the virus increases. At the start of the pandemic, AKI's burden with COVID-19 was estimated to be a minimum of 2.5% to 9%. However, with the disease spreading rapidly to more than 99 countries around the world, incidence rates have increased by more than 18%, which focused on the management of kidney failure in COVID patients. -19 in addition to respiratory failure. Thus, creasing the European dialysis equipment growth rate in up coming years.
RESTRAINTS
However, the poor knowledge of the treatment of kidney disease, the decrease in medical reimbursement for dialysis treatments, the high cost associated with the technology and various risk complications and risks associated with dialysis are major factors, among others, that will restrict the market growth.
OPPORTUNITIES
The increasing technological advancements in the healthcare industry and the increasing modernization of renal dialysis equipment will create new opportunities for the renal dialysis equipment market during the forecast period of 2021 to 2026.
CHALLENGES
Stringent government rules for product launch, frequent product recalls and inability for new product to reach into deeper markets across Europe are said to limit market growth during the forecast period.
This research report on the Europe Dialysis Equipment Market has been segmented and sub-segmented into the following categories
By Type:
By End-User:
By Country:
REGIONAL ANALYSIS
In Europe, Germany is expected to grow by around 4.9% CAGR. The market is expected to be have lucrative growth in market due to increasing research spending, technological advancements, deteriorating human health and the need for innovative and effective therapies.
The growth of the renal dialysis equipment market in other European regions such as Switzerland, France, Sweden etc. is expected to increase exponentially owing to the increase in the number of dialysis centers, government initiatives to produce cost-effective treatments and the increase in the number of patients. In addition, R&D investments and government initiatives to provide better healthcare infrastructure are driving market growth in these regions. This is due to the large number of patients and improved healthcare infrastructure is expected to show rapid growth in this market. The increasing incidence of renal diabetes and obesity in this region is significantly contributing to the growth of the market.
Prominent Companies leading the Europe Dialysis Equipment Market Profiled in the Report are Fresenius Medical Care AG & Co., Gambro AB, Baxter International Inc., Nipro Inc., ALL-MED Medical GmbH, Asahi Kasei Corporation, and others.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Hemodialysis Equipment
5.1.2.1 Hemodialysis Machines
5.1.2.2 Dialyzers
5.1.2.3 Blood Access Device Dialysate
5.1.3 Peritoneal Dialysis Equipment
5.1.3.1 Continuous Cycling Peritoneal Dialysis
5.1.3.2 Continuous Ambulatory Peritoneal Dialysis
5.1.3.3 Intermittent Peritoneal Dialysis
5.1.4 Continuous Renal Replacement Therapy Systems
5.1.5 Dialysis Accessories
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2 End-User
5.3.1 Introduction
5.3.2 In-Center Dialysis
5.3.3 Homecare Dialysis
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Fresenius Medical Care AG & Co.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Gambro AB
8.3 Baxter International Inc.
8.4 Nipro Inc.
8.5 ALLMED Medical GmbH
8.6 Asahi Kasei Corporation
8.7 Celgene Corporation
8.8 Invitrogen
8.9 Cytori Therapeutics
8.10 Retractable Technologies
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
